Cardionerds: A Cardiology Podcast cover image

274. Cardio-Oncology: Cancer Therapy-Related Cardiac Dysfunction (CTRCD) – The Cardiologist Perspective with Dr. Joerg Hermann

Cardionerds: A Cardiology Podcast

00:00

The Evolution of Anti-Cancer Therapy

The first were the conventional chemotherapeutics. They inhibit proliferation of highly proliferative cells while sparing those with not such a high mitonic rate, this would be the normal cells. Then it was felt that we wouldn't be smart enough with these kind of approaches as it's taking a big shotgun or maybe even a tank to just cut down a kilo-rabbit. And so why aren't we a little smarter? Dr. Sellen found out there is carotoxicity in breast cancer patients who have overexpression of EGF receptor 2.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app